Showing results (151-160 of 259) with videos related to
Sort By:
Pageof 26
Molecular and Cellular Biology|February 1, 1989
Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: distinct effects in various tissuesP J Tremblay, F Pothier, T Hoang, et al.Pediatrie|January 1, 1988
[Current results of intensive chemotherapy as salvage with bone marrow graft in highly malignant T lymphomas. Apropos of 10 cases]F Meziane, T Philip, P Biron, et al.The Analyst|March 4, 2011
Detection of acute brain injury by Raman spectral signatureLi-Lin Tay, Roger G Tremblay, John Hulse, et al.Developmental Cell|September 14, 2010
Extended-synaptotagmin-2 mediates FGF receptor endocytosis and ERK activation in vivoSteve Jean, Alexander Mikryukov, Michel G Tremblay, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1990
High-dose etoposide and cisplatin in refractory or recurrent non-Hodgkin's lymphomas (NHL)P Colombat, P Biron, C Patte, et al.IARC Scientific Publications|January 1, 1985
Massive therapy and autologous bone marrow transplantation in very bad prognosis Burkitt's lymphomaT Philip, P Biron, I Philip, et al.Medical and Pediatric Oncology|January 1, 1994
The role of fast neutron therapy in unresectable pelvic osteosarcoma: preliminary reportC Carrie, N Breteau, S Negrier, et al.Cancer Detection and Prevention|January 1, 1996
Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" studyC Linassier, L Fouillard, N Milpied, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphomaT Philip, O Hartmann, P Biron, et al.Pediatrie|January 1, 1988
[Evaluation of the transfer of Algerian children with cancer to the Léon-Bérard center (1984-1987)]F Meziane, T Philip, M Brunat-Mentigny, et al.Pageof 26